表紙
市場調查報告書

新型冠狀病毒感染疾病 (COVID-19) - 流行病學分析與預測:2020年3月

Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - Apr 2020

出版商 GlobalData 商品編碼 931503
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
新型冠狀病毒感染疾病 (COVID-19) - 流行病學分析與預測:2020年3月 Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast - Apr 2020
出版日期: 2020年04月30日內容資訊: 英文 35 Pages
簡介

2019年12月在中國的武漢在最初報告之後,新型冠狀病毒感染疾病 (COVID-19) ,在世界180個國家有846,200案例以上確診。現在,美國在世界受最大影響,今後在歐美其他國家預計更加逐漸增加。重症化風險高的人之中,包含有呼吸疾病、心血管疾病、癌症、糖尿病、罕見疾病等,患有慢性病的人。50歲以上的族群有並存症的可能性高,重症化的風險變高。全球CFR (致命率) 是4.3%。

本報告提供新型冠狀病毒感染疾病 (COVID-19) 調查分析,目前流行病學情形,預測,主要市場預測相關的系統性資訊。

目錄

  • 摘要整理

第1章 目前流行病學情形

  • 目前流行病學情形
  • 感染前10名國家

第2章 主要市場預測

  • 全球主要市場預測
  • 主要4市場預測
  • 主要市場頂峰周預測

第3章 主要9市場上量風險族群

  • 高風險群組分析:COPD
  • 高風險群組分析:糖尿病,心臟病,罕見疾病

第4章 致死率比較

  • 致死率的病例比較
  • 死亡率:各年齡層

第5章 資料不明的事

  • 可利用的資料的缺點

第6章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCHT093

First reported in Wuhan, China, in December 2019, now more than 846,200 confirmed cases of COVID-19 are spread across 187 countries worldwide. The US is now the most heavily affected country worldwide. Forecasts expect new cases to decrease for most countries in the top markets reporting cases except for Russia, which has not yet reached peak.

People at risk for severe COVID-19 include population with underlying health problems, such as respiratory disease, cardiovascular disease, cancer, diabetes, some rare diseases, and diabetes. New analysis available this month for severely obese populations likely to be at risk for sever COVID-19.

The global CFR has increased to more than 7%. The age groups most affected by the disease remains those ages 50 years and older, and men are reported to see higher rates of deaths.

The epidemiology analysis is limited by several data restrictions. Testing availability and criteria differ significantly among countries. All countries' reported confirmed cases underestimate the number of actual infected people. And mortality reporting is not standardized.

The report covers current epidemiology situation, forecast, and analysis of COVID-19 in April 2020, including forecast for key markets.The report will be updated on a monthly basis.

The report provide forecast for peak-week and return-to-normal week that will help the reader plan in this uncertain time.

Scope

  • The Epidemiology report covers the following areas: current epidemiology situation and forecast, populations at risk, case fatality rate, testing and undiagnosed cases comparison, and data limitations.
  • The forecast include three-scenario analysis of peak-week and return-to-normal week analysis for the top markets. The populations at risk area focuses on 9MM (US, France, Germany, Italy, Spain, UK, Japan, China, and South Korea) and provides size of the populations that have COPD, heart disease, diabetes, select rare diseases and diabetes.
  • The case fatality rate area provides comparison in case fatality and proprotion of deaths by age in six major markets (Netherlands, China, South Korea, US, and Italy). Data limitations provide readers with in-depth understanding of the caveats surronding the COVID-19 data.

Reasons to Buy

  • Obtain in-depth understanding of epidemiology data for COVID-19.

Table of Contents

  • Executive Summary
  • Contents

1 Current Epidemiology Situation

  • 1.1 Current Epidemiology Situation
  • 1.2 New Cases Trend in Top 10 Infected Countries

2 Forecast for Key Markets

  • 2.1 Infection Peak and Decline Forecasts for Select Countries
  • 2.2 Epidemic Curves and Projections for Select Countries

3 High-Risk Populations in Nine Major Markets

  • 3.1 High-Risk Group Analysis
  • 3.2 High-Risk Group Analysis: Diabetes, Heart Disease, and Severe Obesity

4 Case Fatality Rate Comparison

  • 4.1 Case Fatality Rate Comparison
  • 4.2 Proportion of Deaths by Age Group
  • 4.3 Proportion of Deaths by Sex

5 Testing and Undiagnosed Case Comparison

  • 5.1 Proportion of Tested Population Diagnosed with COVID-19
  • 5.2 Studies of Asymptomatic Cases Estimate a Much Higher Case Count than Suggested by Official Reports

6. Data limitations

  • 6.1 Drawbacks to Available Data

7 Appendix

  • 7.1 Methodology
  • 7.2 Abbreviations
  • 7.3 Related Reports
  • 7.4 Sources
  • 7.5 About the Authors
  • 7.6 About GlobalData
  • 7.7 Contact Us

List of Tables

  • Table 1. Current Epidemiology Situation
  • Table 2. Top 10 Infected Countries
  • Table 3. Estimated Peak Weeks and Decline to Zero New Cases Weeks for Top Infected Countries (Excluding China)​
  • Table 4. Case Fatality Rates by Age Group

List of Figures

  • Figure 1. Projections of Daily New Confirmed Cases for Select Countries, Since 100th Confirmed Case​
  • Figure 2. COVID-19 in Patients with Underlying Health Conditions (Respiratory Disease, Cardiovascular Disease, Cancer, Obesity Class III, Diabetes, and Selected Rare Disease) in the*Nine Major Markets (9MM)
  • Figure 3. COVID-19 in Patients with Diabetes in Nine Major Pharmaceutical Markets
  • Figure 4. COVID-19 in Patients with Heart Disease in Nine Major Pharmaceutical Markets
  • Figure 5. COVID-19 in Patients with Severe Obesity in*Nine Major Pharmaceutical Markets
  • Figure 6. Case Fatality Rates by Age Group
  • Figure 7. Proportion of Deaths by Age Group
  • Figure 8. Proportion of Deaths by Sex
  • Figure 9. Cumulative Tested Population, Cumulative Confirmed Cases, and Positive Testing Rate
  • Figure 10. Undiagnosed and Diagnosed Cases: Modelling Estimate Based on Real-World Data*